Gsk (GSK) Common Equity (2009 - 2026)
Gsk (GSK) posted quarterly Common Equity of $23.0 billion for Q2 2026, up 20.35% year-over-year from $19.1 billion in Q2 2025, and down 1.88% quarter-over-quarter from $23.5 billion in Q1 2026.
Gsk (GSK) Common Equity (2009 - 2026) Analysis & Trends
Gsk's Common Equity history runs 18 years deep, the most recent figure standing at $23.0 billion for Q2 2026.
- In Q2 2026, Common Equity rose 20.35% year-over-year to $23.0 billion; the TTM figure through Jun 2026 stood at $23.0 billion (up 20.35% YoY), while the FY2025 annual figure was $21.0 billion, up 20.39% from the prior year.
- Common Equity for Q2 2026 stood at $23.0 billion, down from $23.5 billion in the prior quarter.
- The five-year high for Common Equity was $36.0 billion in Q1 2022, with the low at $10.3 billion in Q3 2022.
- The 5-year median for Common Equity is $17.4 billion (2024), against an average of $19.0 billion.
- The sharpest annual moves came in 2022 and 2023: Common Equity plunged 65.74% in 2022, then jumped 55.61% in 2023.
- Gsk's Common Equity stood at $12.4 billion in 2022, then rose by 27.75% to $15.9 billion in 2023, then climbed by 10.49% to $17.5 billion in 2024, then gained by 20.96% to $21.2 billion in 2025, then climbed by 8.58% to $23.0 billion in 2026.
- Business Quant data shows GSK's Common Equity at $23.0 billion in Q2 2026, $23.5 billion in Q1 2026, and $21.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 106.07 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 23.05 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 80.86 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.05 Bn |
| Mar 31, 2026 | 23.49 Bn |
| Dec 31, 2025 | 21.22 Bn |
| Sep 30, 2025 | 21.26 Bn |
| Jun 30, 2025 | 19.15 Bn |
| Mar 31, 2025 | 17.20 Bn |
| Dec 31, 2024 | 17.55 Bn |
| Sep 30, 2024 | 17.48 Bn |
| Jun 30, 2024 | 17.38 Bn |
| Mar 31, 2024 | 16.78 Bn |
| Dec 31, 2023 | 15.88 Bn |
| Sep 30, 2023 | 15.98 Bn |
| Jun 30, 2023 | 15.22 Bn |
| Mar 31, 2023 | 13.75 Bn |
| Dec 31, 2022 | 12.43 Bn |
| Sep 30, 2022 | 10.27 Bn |
| Jun 30, 2022 | 28.51 Bn |
| Mar 31, 2022 | 36.03 Bn |
| Dec 31, 2021 | 28.77 Bn |
| Sep 30, 2021 | 29.98 Bn |